Our study findings are also contrary to an earlier study by Qin et al., which re-ported that LIFR functions as a metastasis suppressor in HCC by negatively regulating the phosphoinositide 3-kinase/AKT pathway (Luo et al., 2015). Here, LIFR is linked to hepatocellular carcinoma.